Ben J Friedman

19PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosisNanoscale characterisationMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Dec 19, 2025
Sclerosing melanocytic tumors with MAP2K1 in frame deletions and 15q gains: A distinctive pathway of nevogenesis with reproducible morphology.

Ben J Friedman, Olena Kis, Brandon Shaw

|Aug 05, 2025
Solitary Cutaneous Xanthogranuloma With DNMT3A Mutation Arising Postallogenic Transplant in a Patient With T-Cell Acute Lymphoblastic Leukemia.

Julia A Rinck, Wyatt Boothby-Shoemaker, Ben J Friedman

|May 02, 2025
Response to "Appropriate Statistical Methods to Assess Cross-Study Diagnostic 23-Gene Expression Profile Test Performance for Cutaneous Melanocytic Neoplasms".

Jesse Veenstra, Wyatt Boothby-Shoemaker, Ben J Friedman

|Oct 27, 2024
Spitz-Type Proliferative Nodules Arising Within a Large Congenital Melanocytic Nevus Harboring a Novel LMNA-RAF1 Fusion.

Gautham Vellaichamy, Janet Poulik, Nallasivam Palanisamy

|Feb 27, 2024
Unresectable infantile myofibroma discovered in utero.

Shannon Gurley, Ben J Friedman, Tor Shwayder

|Dec 27, 2023
Sclerosing melanocytic tumors with MAP2K1 in-frame deletions and copy number gains in 15q: A distinctive pathway of nevogenesis.

J Hamad, B Shaw, L Kohen

Pageof 4

Frequent Collaborators

4 joint publications

Tor Shwayder

3 joint publications

Jesse Veenstra

2 joint publications

A Tisack

2 joint publications

Allison Zarbo